the clinical trial of goat anti-Hp antibodies milk

The Clinical Therapy Effect of Goat anti-Helicobacter pylori Antibodies Milk in Helicobacter pylori

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-PRC-14005207

Enrollment

Unknown

Registered

2014-09-04

Start date

2013-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection disease

Interventions

trial group:goat anti-Hp antibodies milk

control group:goat anti-Hp antibodies milk

Eligibility

Sex/Gender

All

Age

21 Years to 67 Years

Inclusion criteria

Inclusion criteria: Person who to be more than 18 years old, no previous treatment for the Helicobacter pylori infection, not having a chronic decompensated, no use of anti-inflammatory or antibiotic drugs within 4 weeks prior to enrollment.

Exclusion criteria

Exclusion criteria: patients who were pregnant or breastfeeding, patients over 80 years or with a history of gastrointestinal surgery and patients with erosive esophagitis or users of low-dose aspirin. Patients with difficulty to understand the treatment or to report disease symptoms and adverse effects were also excluded. goat milk intolerance,significant systemic comorbidity and use of antibiotics within four weeks before the start of the study.

Design outcomes

Secondary

Measure	Time frame
C14 urea breath tes;	—

Countries

China

Contacts

Public ContactShan baoen

baoenshan62@163.com+86 15132165189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026